Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Innate Pharma
  6. Calendar
    IPH   FR0010331421

INNATE PHARMA

(IPH)
  Report
Real-time Euronext Paris  -  11:37 2022-09-23 am EDT
2.334 EUR   -3.79%
09/23Innate Pharma Says Lacutamab Antibody Showed 'Clinical Responses' in Phase 2 Trial in Patients With Mycosis Fungoides
MT
09/23Innate Pharma SA Presents Data From Ongoing Phase 2 TELLOMAK Trial Demonstrating Clinical Activity of Lacutamab in Advanced Mycosis Fungoides
CI
09/19Top Premarket Decliners
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Event chart INNATE PHARMA
Upcoming events on INNATE PHARMA
11/14/22 Q3 2022 Sales and Revenue Release
Past events on INNATE PHARMA
09/15/22 | 08:00am Interim 2022 Earnings Call
09/15/22 | 01:00am Interim 2022 Earnings Release
09/12/22 H.C. Wainwright Global Investment Conference
09/07/22 Citi BioPharma Conference
08/08/22 BTIG Biotechnology Conference
06/30/22 Evenement Corporate Access Portzamparc Conference
06/16/22 Citi European Healthcare Conference
05/23/22 H.C. Wainwright Global Life Sciences Investment Conference
05/20/22 | 04:30am Annual General Meeting
05/10/22 | 08:00am Q1 2022 Sales and Revenue Call
Past dividends on INNATE PHARMA

- No events available -

Annual results
Fiscal Period : December201720182019202020212022
Sales
M €
Released
Forecast
Spread
44,0
56,3
-22%
94,0
64,4
46%
85,8
90,6
-5,3%
70,5
86,1
-18%
24,7
48,1
-49%
 
53,1
 
Operating income
(EBITDA)
M €
Released
Forecast
Spread
-35,6
-8,92
-299%
12,5
-31,1
140%
-10,5
-11,3
7,3%
38,3
-23,5
263%
-43,2
-41,7
-3,6%
 
-8,49
 
Operating profit
(EBIT)
M €
Released
Forecast
Spread
-40,0
-16,7
-139%
5,15
-19,6
126%
-27,1
-16,3
-66%
-18,5
-27,1
31%
-47,8
-45,9
-4,1%
 
-24,2
 
Pre-Tax Profit
(EBT)
M €
Released
Forecast
Spread
-48,0
-22,4
-114%
2,72
8,80
-69%
-20,8
-2,44
-752%
-64,0
-22,5
-185%
-52,8
-48,0
-10,0%
 
-23,1
 
Net income
M €
Released
Forecast
Spread
-48,4
-21,2
-129%
3,05
-13,1
123%
-20,8
-9,95
-109%
-64,0
-23,3
-174%
-52,8
-43,5
-21%
 
-26,8
 
EPS
Released
Forecast
Spread
-0,89
-0,37
-138%
0,05
-0,10
152%
-0,31
-0,14
-124%
-0,81
-0,70
-15%
-0,66
-0,79
17%
 
-0,19
 
Announcement Date03/08/201803/20/201903/10/202003/18/202103/24/2022-
Quarterly results
Fiscal Period : December2020 S12020 S22021 S12021 S22022 S12022 S2
Sales
M €
Released
Forecast
Spread
36,7
36,7
0,24%
33,7
57,0
-41%
15,7
28,0
-44%
9,02
22,1
-59%
45,6
41,6
9,5%
 
12,1
 
Operating profit
(EBIT)
M €
Released
Forecast
Spread
-8,35
-27,4
70%
-10,2
-11,1
7,8%
-25,4
-23,8
-7,0%
-22,4
-23,2
3,4%
8,49
-20,5
141%
 
-37,4
 
Pre-Tax Profit
(EBT)
M €
Released
Forecast
Spread
-10,3
-24,5
58%
-53,7
-10,5
-413%
-23,7
-21,9
-8,1%
-21,8
-24,2
9,9%
6,38
-21,3
130%
 
-37,4
 
Net income
M €
Released
Forecast
Spread
-10,3
-24,5
58%
-53,7
-1,81
-2 870%
-23,7
-21,9
-8,1%
-29,1
-17,0
-71%
6,30
-21,3
130%
 
-39,7
 
EPS
Released
Forecast
Spread


 


 
-0,30
-0,34
12%
-0,36
-0,27
-33%
0,08
-0,25
132%
 
-0,46
 
Announcement Date09/08/202003/18/202109/15/202103/24/202209/15/2022-
Previous year Next Year
Upcoming sector events for INNATE PHARMA
More events
Past sector events for INNATE PHARMA
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise